Skip navigation
Speakers

A Forum for Emerging and Innovative Pharma, Biotech and Device Companies

October 17-18, 2017
  • San Francisco, CA

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC;
former FCPA Violator and FBI/UK Cooperator

Chrissy Bradshaw, JD
Vice President
Porzio Life Sciences

Ben Carmel
Managing Director, San Francisco
Polaris

Richard J. Ciamacca
Vice President, Secretary and General Counsel
Amring Pharmaceuticals

Valorie Ciechanowski
Compliance and Privacy Officer
Advanced Bionics

Danielle Davis
Director, Compliance
Insys Therapeutics

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Mark Farrar
Managing Director
Navigant

Francisco Ribeiro Filho
Senior Director, Global Head of Compliance
Sarepta Therapeutics

Dan Guggenheim
Chief Compliance Officer
Theranos

Ernie Hernandez
Senior Director, Healthcare Compliance Officer
Adamas Pharmaceuticals, Inc.

Chris Hull
Consultant
Potomac River Partners

Eric Jen
Associate Director, Compliance
Heron Therapeutics

Jeremy Livianu
Director, Legal Affairs, Compliance and Privacy Officer
Nevro

Daniel O'Connor
Senior Vice President
NXLevel Solutions

John Oroho
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

Jim Schneider
Associate Director
Seattle Genetics

Sherry Schnell
Chief Compliance Officer, Associate General Counsel
Neurocrine Biosciences, Inc.

Gregg Shapiro
Assistant United States Attorney, District of Massachusetts
U.S. Department of Justice

David Walk
Assistant United States Attorney, District of New Jersey
U.S. Department of Justice

Matt Werner
Vice President, Chief Compliance Officer
Bio-Rad Laboratories, Inc.

Sarah Whipple
Senior Corporate and Compliance Counsel
Akebia Therapeutics, Inc.

Jon Wilkenfeld
President
Potomac River Partners

Sara Winslow
Chief, Civil Division
U.S. Attorney’s Office for the Northern District of California

Jane Wright-Mitchell
Chief Legal Officer
AcelRx Pharmaceuticals, Inc.

Richard Bistrong
CEO, Front-Line Anti-Bribery LLC;
former FCPA Violator and FBI/UK Cooperator

Chrissy Bradshaw, JD
Vice President
Porzio Life Sciences

Ben Carmel
Managing Director, San Francisco
Polaris

Richard J. Ciamacca
Vice President, Secretary and General Counsel
Amring Pharmaceuticals

Valorie Ciechanowski
Compliance and Privacy Officer
Advanced Bionics

Danielle Davis
Director, Compliance
Insys Therapeutics

Stefanie Doebler
Of Counsel
Covington & Burling LLP

Mark Farrar
Managing Director
Navigant

Francisco Ribeiro Filho
Senior Director, Global Head of Compliance
Sarepta Therapeutics

Dan Guggenheim
Chief Compliance Officer
Theranos

Ernie Hernandez
Senior Director, Healthcare Compliance Officer
Adamas Pharmaceuticals, Inc.

Chris Hull
Consultant
Potomac River Partners

Eric Jen
Associate Director, Compliance
Heron Therapeutics

Jeremy Livianu
Director, Legal Affairs, Compliance and Privacy Officer
Nevro

Daniel O'Connor
Senior Vice President
NXLevel Solutions

John Oroho
Executive Vice President, Chief Strategy Officer
Porzio Life Sciences, LLC

Jim Schneider
Associate Director
Seattle Genetics

Sherry Schnell
Chief Compliance Officer, Associate General Counsel
Neurocrine Biosciences, Inc.

Gregg Shapiro
Assistant United States Attorney, District of Massachusetts
U.S. Department of Justice

David Walk
Assistant United States Attorney, District of New Jersey
U.S. Department of Justice

Matt Werner
Vice President, Chief Compliance Officer
Bio-Rad Laboratories, Inc.

Sarah Whipple
Senior Corporate and Compliance Counsel
Akebia Therapeutics, Inc.

Jon Wilkenfeld
President
Potomac River Partners

Sara Winslow
Chief, Civil Division
U.S. Attorney’s Office for the Northern District of California

Jane Wright-Mitchell
Chief Legal Officer
AcelRx Pharmaceuticals, Inc.